Companion Dx Pioneers Test Variety Of Business Models
This article was originally published in The Pink Sheet Daily
Executive Summary
Regulatory environment opens up, but alliances with Pharma have yet to take off.
You may also be interested in...
Diabetes Start-Up Tethys Gets $25 Million To Speed Rollout Of Molecular Test
Real-world impact of predictive test questioned. Skeptics say patients at risk will be loath to change, test or no test.
Diabetes Start-Up Tethys Gets $25 Million To Speed Rollout Of Molecular Test
Real-world impact of predictive test questioned. Skeptics say patients at risk will be loath to change, test or no test.
Companion Diagnostics Spark Pharma Deals - But Still Mostly For Cancer
An inaugural review of the diagnostics sector newly published by PricewaterhouseCoopers contends that growing interest in personalized medicine is a key factor driving partnering deals between pharmaceutical companies and diagnostics developers